The Indian pharmaceutical sector showed mixed performance on February 5, 2026, as of around 10:21 AM IST. The broader market was lower, with the BSE Sensex around 83,525 (down ~0.35%) and NSE Nifty 50 around 25,670 (down ~0.41%). The Nifty Pharma index was trading in negative territory in recent sessions (e.g., around 22,125 on Feb 4, down 0.34%), with the sector experiencing pressure amid overall market declines.

The provided data lists prices and percentage changes for various pharma and related healthcare stocks on BSE and NSE at that time. Most stocks were trading lower, reflecting cautious sentiment in the sector.

Key Observations from the Data

  • Top Gainers (positive changes):
    • Shukra Pharma: +4.99% (BSE)
    • Alembic Pharma: +2.00% (BSE), +1.32% (NSE)
    • Artemis Medicare Services: +2.03% (BSE), +2.29% (NSE)
    • Corona Remedies Ltd.: +1.39% (BSE), +1.51% (NSE)
    • Aarti Drugs: +1.11% (BSE), +0.97% (NSE)
    • Metropolis Healthcare: +1.65% (BSE), +1.11% (NSE)
    • Lupin: +0.50% (BSE), +0.62% (NSE)
    • Dr. Reddy’s Lab: +0.16% (BSE), +0.37% (NSE)
    • Cipla: nearly flat to slight positive on NSE (+0.06%)
  • Top Losers (notable negative changes):
    • Jubilant Industries: -4.08% (BSE), -4.46% (NSE)
    • Emcure Pharmaceuticals Ltd.: -4.05% (BSE), -3.76% (NSE)
    • Suven Life Sciences: -3.69% (BSE), -3.40% (NSE)
    • Windlas Biotech: -3.48% (BSE), -1.92% (NSE)
    • Advanced Enzyme Technologies: -3.28% (BSE), -3.20% (NSE)
    • Sequent Scientific: -3.23% (BSE), -3.01% (NSE)
    • Cohance Lifesciences: -3.20% (BSE), -2.97% (NSE)
    • Indraprastha Medical: -3.13% (BSE), -2.88% (NSE)
    • Healthcare Global Enter.: -3.04% (BSE), -2.86% (NSE)
  • Major Large-Cap Stocks (relatively stable or mild declines):
    • Sun Pharma: -0.58% (BSE), -0.51% (NSE)
    • Divi’s Laboratories: -0.82% (BSE), -0.74% (NSE)
    • Cipla: -0.01% (BSE), +0.06% (NSE)
    • Dr. Reddy’s Laboratories: +0.16% (BSE), +0.37% (NSE)
    • Torrent Pharma: -1.58% (BSE), -1.23% (NSE)
    • Abbott India: -0.87% (BSE), -0.70% (NSE)
    • Zydus Lifesciences: nearly flat (-0.05% on both)
  • Other Notes:
    • Many mid- and small-cap pharma stocks saw sharper declines (e.g., over 2-4% in several cases).
    • Some stocks like Wyeth showed unusual data (e.g., extreme percentage on NSE), likely due to low liquidity or data anomaly.
    • The sector’s performance aligned with broader market weakness, with no strong positive catalyst evident at the snapshot time.

This snapshot captures intraday movements as of approximately 10:21 AM IST on February 5, 2026. Stock prices fluctuate throughout the trading session due to market conditions, news, and trading volume. For the most current data, refer to official exchanges (BSE/NSE) or financial platforms.

TOPICS: Pharma sector